Analysis reportAll specifications met
Retatrutide 30mg
Peptide Stock ref. PSV-2609-RT30-03
Purity99.87%HPLC
Content per vial30.486 mg101.6% of 30 mg label claim
IdentityConfirmedHPLC
Test results
| Test | Specification | Result | Outcome |
|---|---|---|---|
| Identity | Retatrutide | Conforms | Pass |
| Purity (HPLC) | > 98.0% | 99.873% | Pass |
| Quantity per vial | Measured | 30.486 mg (101.6% of claim) | Reported |
About this report
- Sample received by the lab 21 September 2026; report issued 26 September 2026.
- Results relate to the sample tested. For laboratory research use only.